A COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF FIDAXOMICIN FOR TREATING CLOSTRIDIUM DIFFICILE PATIENTS IN GERMANY

被引：1
|
作者：
Watt, M. [1 ]
McCrea, C. [2 ]
Johal, S. [3 ]
Posnett, J. [2 ]
Nazir, J. [1 ]
机构：
[1] Astellas, Chertsey, Surrey, England
[2] Heron Commercializat, London, England
[3] Parexel Int, London, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1357
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN33
引用
收藏
页码：A233 / A233
页数：1
相关论文
共 50 条
  • [31] A cost-effectiveness and budget impact analysis of apremilast in patients with psoriatic arthritis in Italy
    Capri, Stefano
    Migliore, A.
    Loconsole, F.
    Barbieri, Marco
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (04) : 353 - 361
  • [32] Effectiveness and cost-effectiveness of a Clostridium difficile vaccine candidate in a hospital setting
    Champredon, David
    Shoukat, Affan
    Moghadas, Seyed M.
    VACCINE, 2020, 38 (11) : 2585 - 2591
  • [33] A cost-effectiveness and budget impact analysis of apremilast in patients with psoriasis in the Italian setting
    Barbieri, Marco
    Loconsole, F.
    Migliore, A.
    Capri, S.
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (04) : 362 - 370
  • [34] Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection
    Lapointe-Shaw, Lauren
    Tran, Kim L.
    Coyte, Peter C.
    Hancock-Howard, Rebecca L.
    Powis, Jeff
    Poutanen, Susan M.
    Hota, Susy
    PLOS ONE, 2016, 11 (02):
  • [35] Cost-Effectiveness Analysis of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
    Varier, Raghu U.
    Biltaji, Eman
    Smith, Kenneth J.
    Roberts, Mark S.
    Jensen, M. Kyle
    LaFleur, Joanne
    Nelson, Richard E.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (04): : 438 - 444
  • [36] Is Fidaxomicin the Drug of Choice for Treating Clostridium difficile-Associated Diarrhea in Patients With Cancer?
    Green, Myke R.
    Acharya, Utkarsh H.
    Yeager, Andrew M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4376 - 4378
  • [37] Cost-effectiveness in Clostridium difficile treatment decision-making
    Mark JC Nuijten
    Josbert J Keller
    Caroline E Visser
    Ken Redekop
    Eric Claassen
    Peter Speelman
    Marja H Pronk
    World Journal of Clinical Cases, 2015, (11) : 935 - 941
  • [38] Cost-effectiveness in Clostridium difficile treatment decision-making
    Nuijten, Mark J. C.
    Keller, Josbert J.
    Visser, Caroline E.
    Redekop, Ken
    Claassen, Eric
    Speelman, Peter
    Pronk, Marja H.
    WORLD JOURNAL OF CLINICAL CASES, 2015, 3 (11) : 935 - 941
  • [39] Cost-effectiveness analysis and budget constraints
    Patton, MF
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (19): : 1465 - 1465
  • [40] COST-EFFECTIVENESS OF VARIOUS CLOSTRIDIUM DIFFICILE INFECTION (CDI) TREATMENTS IN PATIENTS WITH RECURRENT INFECTIONS
    Massachi, S.
    Hay, J. W.
    VALUE IN HEALTH, 2014, 17 (03) : A273 - A274
12345